These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1286745)

  • 1. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.
    Brunko P
    Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing authorization of veterinary medicinal products in Poland.
    Sztabińska-Koncka H; Lewicki J
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory framework of immunologicals in the European Union.
    Sauer F
    Biologicals; 1994 Dec; 22(4):307-11. PubMed ID: 7779353
    [No Abstract]   [Full Text] [Related]  

  • 4. European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
    Celis P; Silvester G
    Dev Biol (Basel); 2004; 118():3-10. PubMed ID: 15645667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary vaccines in an economic and sociopolitical context. The viewpoint of the veterinary pharmaceutical industry.
    Gug M
    Dev Biol Stand; 1992; 79():31-6. PubMed ID: 1286762
    [No Abstract]   [Full Text] [Related]  

  • 6. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
    Gay CG
    Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International harmonisation of regulatory requirements.
    Holmes M; Hill RE
    Rev Sci Tech; 2007 Aug; 26(2):415-20. PubMed ID: 17892161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [POM].
    van den Ekker W
    Tijdschr Diergeneeskd; 2006 Jul; 131(13):496. PubMed ID: 16866166
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology, animal health and animal welfare within the framework of European Union legislation.
    De Simone FI; Serratosa J
    Rev Sci Tech; 2005 Apr; 24(1):89-99. PubMed ID: 16110879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is quality still important?].
    van Bruinessen A
    Tijdschr Diergeneeskd; 2007 Dec; 132(23):935. PubMed ID: 18085181
    [No Abstract]   [Full Text] [Related]  

  • 13. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEC legislation of medicinal products of biological origin.
    Brunko P; Sauer F
    Dev Biol Stand; 1991; 75():21-5. PubMed ID: 1794622
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of immunological veterinary medicinal products in the European Union.
    Brunko P
    Rev Sci Tech; 1995 Dec; 14(4):1133-41. PubMed ID: 8639951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biotechnology, especially genetic modification, and legislation].
    de Sitter H; Peters PW
    Tijdschr Diergeneeskd; 2002 May; 127(10):322-30. PubMed ID: 12056264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of manufacture--the EC point of view.
    Meyer P
    Dev Biol Stand; 1992; 79():159-62. PubMed ID: 1286750
    [No Abstract]   [Full Text] [Related]  

  • 18. US biotech prepares to fight generic biologics.
    Reid B
    Nat Biotechnol; 2002 Apr; 20(4):322. PubMed ID: 11923820
    [No Abstract]   [Full Text] [Related]  

  • 19. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(185):51074-84. PubMed ID: 10185809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of medicinal products derived from human blood or plasma in the European Community.
    Brunko P
    Dev Biol Stand; 1993; 81():269-71. PubMed ID: 8174813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.